Resistance to gemcitabine in a lymphoma cell line resistant to Fas-mediated apoptosis

Stefania Grimaudo, Maria Meli, Luisa Dusonchet, Natale D'Alessandro, Monica Notarbartolo Di Villarosa, Giuliana Papoff, Manlio Tolomeo, Giovina Ruberti, Luciano Rausa

Risultato della ricerca: Articlepeer review

7 Citazioni (Scopus)


Background: The T-cell lymphoma cell line HuT78B1, selected for resistance to Fas-mediated apoptosis, resulted unexpectedly resistant to the apoptotic and cytotoxic effects of gemcitabine (dFdC). We investigated whether this resistance was due to the impairment of the Fas/Fas-ligand (FasL) system. Materials and Methods: dFdC effects were studied in HuT78B1 and in the parental Fas-sensitive HuT78 cells exposed to inhibitors of the Fas/FasL system. Results: FasL- and Fas-blocking antibodies did not interfere with dFdC-induced apoptosis in HuT78 cells, whereas inhibitors of caspase-8, -9, -1 or -3 had partial inhibitory effects. Notably, in HuT78B1 cells there was a markedly reduced dFdC accumulation notwithstanding a high activity of the activating enzyme deoxycytidine kinase. dFdC accumulation in HuT78 cells was unaffected by a Fas-blocking antibody. Conclusion: This is the first time that the selection of a Fas-resistant cell line led to the isolation of a cell clone unable to accumulate the deoxycytidine analog dFdC. Our results show that this alteration is independent from the impairment of the Fas/FasL system.
Lingua originaleEnglish
pagine (da-a)851-857
Numero di pagine7
RivistaAnticancer Research
Stato di pubblicazionePublished - 2004

All Science Journal Classification (ASJC) codes

  • ???subjectarea.asjc.2700.2730???
  • ???subjectarea.asjc.1300.1306???


Entra nei temi di ricerca di 'Resistance to gemcitabine in a lymphoma cell line resistant to Fas-mediated apoptosis'. Insieme formano una fingerprint unica.

Cita questo